210
Cancer of the Prostate: Molecular Genetics
Bibliography
Primary Literature
Alexandrow,
M.G.,
Moses,
H.L.
(1995)
Transforming growth factor
α
and cell cycle
regulation,
Cancer Res.
55
, 1452–1457.
Allen, M.V., Smith, G.J., Juliano, R., et al. (1998)
Downregulation
of
the
beta4
integrin
subunit in prostatic carcinoma and prostatic
intraepithelial neoplasia,
Hum. Pathol.
29
,
311–318.
Avery, A., Standberg, M.D. (1992) Chromosomal
abnormalities and related events in prostate
cancer,
Hum. Pathol.
23
, 368–380.
Bakin, R.E.,
Gioeli, D.,
Bissonette, E.A.,
We-
ber, M.J. (2003) Attenuation of Ras signaling
restores androgen sensitivity to hormone-
refractory C4-2 prostate cancer cells,
Cancer
Res.
63
(8), 1975–1980.
Bakin, R.E.,
Gioeli, D.,
Sikes, R.A.,
Bis-
sonette, E.A., Weber, M.J. (2003) Constitutive
activation of the ras/mitogen-activated protein
kinase signaling pathway promotes andro-
gen hypersensitivity in LNCaP prostate cancer
cells,
Cancer Res.
63
(8), 1981–1989.
Bedford,
M.T.,
van
Helden,
P.D.
(1987)
Hypomethylation of
DNA in
pathological
conditions of the human prostate,
Cancer Res.
47
, 5274–5276.
Behrens, J., Mareel, M.M., VanRoy, F.M., Birch-
meier, W. (1989) Dissecting tumor cell inva-
sion: epithelial cells acquire invasive properties
after loss of uvomorulin-mediated cell-cell ad-
hesion,
J. Cell Biol.
108
, 2435–2447.
Blackburn, E.H. (1991) Structure and function of
telomeres,
Nature
350
, 569–573.
Bochum, S.,
Paiss, T.,
Vogel, W.,
Herkom-
mer, K., Hautmann, R., Haeussler, J. (2002)
Con±rmation of the prostate cancer suscep-
tibility locus HPCX in a set of 104 German
prostate cancer families,
Prostate
52
(1), 12–19.
Bookstein, R., MacGrogan, D., Hilsenbeck, S.G.,
et al. (1993) p53 is mutated in a subset of
advanced-stage prostate cancers,
Cancer Res.
53
, 3369–3373.
Bookstein, R.,
Shew, J.-Y.,
Chen, P.L.,
et al.
(1990)
Suppression
of
tumorigenicity
of
human prostate carcinoma cells by replacing
a mutated RB gene,
Science
247
, 712–715.
Bostwick, D.G.,
Pacelli, A.,
Lopez-Beltran, A.
(1996)
Molecular
biology
of
prostate
intraepithelial neoplasia,
Prostate
29
, 117–134.
Bova, G.S., Carter, B.S., Bussemakers, M.J., et al.
(1993) Homozygous deletion and frequent
allelic loss of chromosome 8p22 loci in human
prostate cancer,
Cancer Res.
53
, 3869–3873.
Boyer, J., Umar, A., Risinger, J., et al. (1995)
Microsatellite
instability,
mismatch
repair
de±ciency, and genetic defects in human
cancer cell lines,
Cancer Res.
55
, 6063–6070.
Bronner, C.E., Baker, S.M., Morrison, P.T., et al.
(1994) Mutation in the DNA mismatch repair
gene homologue hMLH1 is associated with
hereditary non-polyposis colon cancer,
Nature
368
, 258–261.
Brooks, J.D.,
Bova, G.S.,
Isaacs, W.B.
(1995)
Allelic loss of the retinoblastoma gene in
primary human prostatic adenocarcinomas,
Prostate
26
, 35–39.
Brooks, J.D.,
Bova, G.S.,
Ewing, C.M.,
et al.
(1996)
An
uncertain
role
for
p53
gene
alterations in human prostate cancers,
Cancer
Res.
56
, 3814–3822.
Brooks, J.D., Weinstein, M., Lin, X., et al. (1998)
CG island methylation changes near the
GSTP1
gene
in
prostatic
intraepithelial
neoplasia,
Cancer Epidemiol Biomarkers Prev
7
, 531–536.
Brothman, A.R., Peehl, D.M., Patel, A.M., Mc-
Neal, J.E. (1990) Frequency and pattern of
karyotypic abnormalities in human prostate
cancer,
Cancer Res.
50
, 3795–3803.
Brown, J.A.,
Alcaraz, A.,
Takahashi, S.,
et al.
(1994) Chromosomal aneusomies detected by
fluorescent in situ hybridization analysis in
clinically localized prostate carcinoma,
J. Urol.
152
, 1157–1162.
Buchman, E.C.,
Nayak, R.N.,
Bushman, W.
(1995) Immunohistochemical staining of ras
p21: staining in benign and malignant prostate
tissue,
J. Urol.
153
, 233–237.
Buttyan, R., Sawczuk, I.S., Benson, M.C., et al.
(1987) Enhanced expression of the c-myc
protooncogene in high-grade human prostate
cancers,
Prostate
11
, 327–337.
Cairns, P., Okami, K., Halachmi, S., et al. (1997)
Frequent inactivation of PTEN/MMAC1 in
primary
prostate
cancer,
Cancer Res.
57
,
4997–5000.
Cairns, P., Polascik, T.J., Eby, Y., et al. (1995)
Frequency
of
homozygous
deletion
at
p16/CDKN2 in primary human tumors,
Nat.
Genet.
11
, 210–212.
C
a
n
n
o
n
,L
.
,B
i
s
h
o
p
,D
.
T
.
,S
k
o
l
n
i
c
k
,M
.
,e
t
a
l
.
(1982)
Genetic
epidemiology
of
prostate
previous page 884 Encyclopedia of Molecular Cell Biology and Molecular Medicine read online next page 886 Encyclopedia of Molecular Cell Biology and Molecular Medicine read online Home Toggle text on/off